Female authors are underrepresented as sole and first authors and as members of authorship teams in readings for undergraduate college courses, finds a new analysis from the Brown School at Washington University in St. Louis.
Non-pharmaceutical interventions such as voluntary shelter-in-place, quarantines, and other steps taken to control the SARS-CoV-2 virus can reduce the peak number of infections, daily infection rates, cumulative infections, and overall deaths, a new study published in the journal PLOS ONE has found.
Johns Hopkins Medicine has launched a new Spanish-language COVID-19 resources portal. This one-stop shop for information in Spanish offers COVID-19 testing sites, information about telemedicine and communicating with health care providers, social distancing tips and resources for children, among other helpful links. The mobile-friendly portal serves community members, patients, faculty and staff members as well as students who need COVID-19 resources and information in Spanish.
Health care leaders have new, improved tools to identify children at the greatest risk of preventable deaths, based on surveys of more than 67 countries around the world by researchers at the UCLA Fielding School of Public Health.
In a program that used three different types of behavioral nudges, a study showed significantly different results for people with different personal and psychological characteristics
In unprecedented times like this, we often reflect on what we as humans can do to better our world. In terms of climate change, there are many ways we can make a difference, whether on a small or large scale, in order to create a sustainable and healthy environment for all.
Compared to high income cities, less developed cities in Brazil have a higher hospitalization rate associated with increased heat exposure, according to a new study published this week in PLOS Medicine by Yuming Guo of the Monash University, Australia, and colleagues.
A large, international study of COVID-19 patients confirmed that cardiovascular disease, hypertension, diabetes, congestive heart failure, chronic kidney disease, stroke and cancer can increase a patient’s risk of dying from the virus.
A new study of asylum seekers in Germany suggests that, among those with symptoms of depression, anxiety, or posttraumatic stress disorder (PTSD), few receive a diagnosis from the health care system, and of those diagnosed, many do not receive treatment.
Results from a large-scale survey of households in Latin America and the Caribbean show that the negative economic impacts of the COVID-19 pandemic have been concentrated among those who had lower incomes prior to the pandemic, according to a study published October 7 in the open-access journal PLOS ONE by Nicolas Bottan of Cornell University, Bridget Hoffmann and Diego Vera-Cossio of the Inter-American Development Bank.
A study conducted at Wake Forest Baptist Health shows that on-scene use of a new protocol and advanced diagnostic equipment can help paramedics better identify patients at high risk for adverse cardiac events.
Some clinicians consider that after a traumatic injury, patients are most likely to survive if they receive medical treatment within one hour—the so-called “golden hour.”
Scientists at the Univ. of Vermont and Univ. of Washington have developed an accurate COVID-19 test that doesn’t use scarce reagents, paving the way for widespread testing in developing countries and industrialized nations like the United States, where reagent supplies are again in short supply.
“Ten simple rules for building an antiracist lab,” is the subject of a paper by scientists at DePaul University in Chicago and the University of California in Merced. The paper is published Oct. 1 in the journal PLOS Computational Biology.
Four out of five people experiencing the recent loss of smell and/or taste tested positive for COVID-19 antibodies—and of those who tested positive, 40 percent did not have cough or fever, reports a new study in PLOS Medicine by Prof. Rachel Batterham at University College London and colleagues.
Rutgers researchers have reported an increased mortality risk in adults with depression who initiated augmentation with newer antipsychotic medications compared to a control group that initiated augmentation with a second antidepressant.